Did You See This Penny Stock Skyrocket?

 

Dynamic Wealth Report | August 10, 2015 Do You Sincerely Want To Get RICH Trading Options?   Learn to trade options from a trading pro… Get his free report right now.  Click this link and submit your email address to get all the details now! The Dream Penny Stock? By Brian Kent, Penny Stock Research It happened again.  It's the dream of penny stock investors everywhere and it happened right in our backyard.   It's the dream of scooping up shares of a tiny penny stock to watch it skyrocket in value, doubling in value overnight.   What a dream.  Well this is no dream, and we really had a penny stock double in value over night.   A stock we talked about days earlier.   It all started earlier this year…    How we found our penny stock gainer!   Earlier this year, I started focusing on a trend we were seeing in the market.  The biotechnology industry is on fire right now.  Stocks are moving higher… big companies are throwing off massive cash and looking to buy small startups… the FDA is finally approving drugs again… and stock prices are rewarding investors.   We noticed this trend and started talking about it months back.   We wrote about it frequently calling out lists of stocks looking strong and sharing our thoughts.   Just 6 or 7 weeks ago, we shared the top 11 NASDAQ stocks you should watch… I even shared How I Found the List Of NASDAQ Penny Stocks In Biotech.   And that's when you asked for more.   You wanted to know how to find awesome penny stocks… so I shared that too.   If you were paying attention, we talked about a single penny stock in the biotech space that ended up doubling in value… overnight!   If you read my article on finding Awesome Penny Stocks, in tip #2 I showed everyone how to uncover great little stocks…   How This FREE Penny Stock Tool Helped Traders DOUBLE Their Money    We showed a sample screen for interesting stocks.  We looked at stocks near their 52-week high and trading for under $5.   In the last 52-weeks, a handful of stocks had moved significantly higher… but were still trading for pennies. One of those stocks was Nymox Pharma $NYMX.   Our free online screener helped us uncover this great little stock.   The company has a number of drugs in development and the stock cratered late last year on news that one of their drug compounds failed.   A few days after we pointed $NYMX out as a big mover and one to look more closely at… the company announced their drug...fexapotide triflutate… showed promise.   As a result, the stock took off like a rocket.     Overnight the stock doubled in value.  Now the stock is up over 505% from the lows set earlier in the year.   It's the dream scenario for any investor… and one that some of you could have captured yourself.   Tell me… did you invest in $NYMX?     Leave a comment on the website and let me know!   Good investing... Brian Kent Note: If you're interested in learning more about Brian Kent's Penny Stock All-Stars premium service… and learning about the stocks we're trading for profit… you can get the inside scoop on penny stocks here. EXPOSED:  Options pro spills the beans on the three best options trades to make right now.     Click this link to discover the truth! Copyright 2015 Hyperion Financial Group, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This email may only be used pursuant to the subscription agreement controlling use of the Dynamic Wealth Report website and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of Hyperion Financial Group, LLC. If you purchase anything through a link in one of our emails or from a link on our website, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. LEGAL DISCLAIMER: Neither Hyperion Financial Group LLC nor any of it's employees, contractors or officers are registered investment advisors or a Broker/Dealer. As such, Hyperion Financial Group, LLC does not offer or provide personalized investment help. Although Hyperion Financial Group, LLC employees and contractors may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees or contractors to you should be considered personalized investment help. Owners and writers may have positions in the securities that are discussed. However, no associated employees or contractors may intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. We accept no compensation from any companies mentioned in our reports. Past performance is no guarantee of future results. All information is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell any security. All opinions, analyses and information contained herein are based on sources believed to be reliable and written in good faith, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. Investments recommended in this publication should only be made after consulting with your financial advisor.

 

This message was sent to ignoble.experiment@arconati.us from: Dynamic Wealth Report | customerservice@hyperionfinancial.com | Hyperion Financial | 20701 N Scottsdale Rd, Ste 107-154 | Scottsdale, AZ 85255

Email Marketing by

Manage Your Subscription